lovastatin has been researched along with Adverse Drug Event in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, Y; Ding, H; Ma, C; Shen, S; Wang, J; Zhang, J | 1 |
| Cam Huong, NT; Farrar, J; Hang, NT; Hue Tai, LT; Khanh, LP; Kien, DTH; Nguyen, CVV; Nhon, VT; Quyen, NTH; Simmons, CP; Tran, NTT; Truong, NT; Van Tram, T; Whitehorn, J; Wills, B; Wolbers, M | 1 |
| Cukierski, MA; Lankas, GR; Wise, LD | 1 |
| Hanson, ML; Kelly, SE; Richards, SM | 1 |
| Pickering, TG | 1 |
1 trial(s) available for lovastatin and Adverse Drug Event
| Article | Year |
|---|---|
Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Adult; Anti-Inflammatory Agents; Dengue; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lovastatin; Male; Placebos; Treatment Outcome; Vietnam; Young Adult | 2016 |
10 other study(ies) available for lovastatin and Adverse Drug Event
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Understanding the "individual drug reaction" from the perspective of the interaction between probiotics and lovastatin in vitro and in vivo.
Topics: Animals; Chromatography, High Pressure Liquid; Cricetinae; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Microbiome; Humans; Liver; Lovastatin; Probiotics | 2023 |
The role of maternal toxicity in lovastatin-induced developmental toxicity.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Animals; Area Under Curve; Body Weight; Bone and Bones; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Embryo, Mammalian; Female; Fetal Weight; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Lovastatin; Maternal Exposure; Organ Size; Pregnancy; Pregnancy, Animal; Rats; Teratogens; Time Factors; Weight Loss | 2004 |
Zooplankton chitobiase activity as an endpoint of pharmaceutical effect.
Topics: Acetylglucosaminidase; Animals; Atorvastatin; Biological Assay; Daphnia; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Environmental Monitoring; Fluoxetine; Heptanoic Acids; Lethal Dose 50; Lovastatin; Pyrroles; Sertraline; Water Pollutants, Chemical; Xenobiotics; Zooplankton | 2008 |
The Food and Drug Administration and over-the-counter statins: an opportunity lost?
Topics: Adult; Aged; Cardiovascular Diseases; Contraindications; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Nonprescription Drugs; Pravastatin; Pregnancy; Self Administration; United States; United States Food and Drug Administration | 2008 |
[2,700 reported adverse effects of drugs in 1991. A large spectrum of new antidepressive agents].
Topics: Adult; Antidepressive Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Indoles; Lovastatin; Male; Simvastatin; Sulfonamides; Sumatriptan; Sweden | 1992 |